eIF4E

PF3D7_0315100 (eIF4E) is the primary mRNA 5' cap-binding protein of Plasmodium falciparum and serves as the cap-recognition subunit that couples 5'-capped transcripts to the translation machinery (PMID:17692399, PMID:34890716). Recombinant eIF4E possesses canonical cap-binding activity and can be used to affinity-purify capped mRNAs from parasite RNA (PMID:17692399), and native eIF4E is the most reproducibly enriched protein in 5' cap affinity pull-downs from asexual-stage parasites, confirming this role in vivo (PMID:34890716). In asexual intraerythrocytic stages, eIF4E interacts with eIF4G and, together with eIF4A, forms the eIF4F translation initiation complex, though the low reproducibility of eIF4A/eIF4G co-enrichment indicates a loose or transient association (PMID:19751846, PMID:34890716); eIF4E and eIF4A co-localize predominantly in the cytoplasm and are together critical for parasite proliferation (PMID:21331256). Beyond canonical initiation, eIF4E participates in a translationally repressive program: in P. berghei gametocytes it is a component of a DOZI/CITH-containing mRNP that stores translationally silent mRNAs, incorporating poly(A)-binding protein but excluding eIF4G (PMID:20169188), and in P. falciparum eIF4E physically interacts with the DEAD-box helicase DOZI (PfDZ50) through DOZI's domain 1, an interaction that can be functionally overcome by exogenous eIF4E to restore translation in vitro (PMID:23562722). No structural model, regulatory phosphorylation, or individual gene-specific loss-of-function phenotype for eIF4E has been characterized in the available corpus.

1. 2007 Medium

   Establishing whether the parasite encodes a functional cap-binding protein was the first step in defining how P. falciparum recognizes mRNA for translation; recombinant eIF4E was shown to bind the 5' cap and to affinity-purify capped mRNAs.

   Evidence Recombinant protein purification and in vitro cap-binding affinity assay

   PMID:17692399

   Open questions at the time

   • Single lab, single method
   • No in vivo confirmation at this stage
   • Cap-binding affinity/specificity not quantified against variant cap structures
2. 2009 Low

   To place eIF4E in the initiation machinery, its interaction with eIF4G was tested, positioning eIF4E as a subunit of the parasite eIF4F complex alongside eIF4A and eIF4G.

   Evidence Protein interaction assay with bioinformatic/structural modeling

   PMID:19751846

   Open questions at the time

   • Single interaction assay with limited methodological detail
   • Binding stoichiometry and affinity not defined
   • No reciprocal in vivo validation
3. 2010 Low

   The subcellular location and functional importance of eIF4E were probed to link cap-binding to parasite growth; eIF4E and eIF4A localize to the cytoplasm and combined knockdown strongly inhibits proliferation.

   Evidence Immunofluorescence co-localization plus combined dsRNA knockdown and growth inhibition assay

   PMID:21331256

   Open questions at the time

   • No eIF4E-alone knockdown data — growth effect is from combined eIF4E/eIF4A dsRNA
   • Off-target effects of dsRNA not excluded
   • Cytoplasmic localization not resolved to specific compartments
4. 2010 Medium

   Whether eIF4E functions only in active initiation or also in translational repression was addressed by characterizing gametocyte mRNP complexes; eIF4E was found in a DOZI/CITH mRNP that stores silent mRNAs and excludes eIF4G.

   Evidence Affinity purification coupled with mass spectrometry from P. berghei gametocytes, with gene-deletion validation of complex components

   PMID:20169188

   Open questions at the time

   • Shown in P. berghei, not P. falciparum
   • eIF4E's specific role within the repressive mRNP not dissected by its own deletion
   • Mechanism of eIF4E partitioning between eIF4F and the mRNP unknown
5. 2013 Medium

   To test whether the eIF4E–DOZI association is direct and functionally consequential, the interaction was mapped and reconstituted; eIF4E binds DOZI domain 1 and exogenous eIF4E relieves DOZI-mediated translational repression in vitro.

   Evidence Co-immunoprecipitation/pulldown, domain mapping, in vitro translation rescue assay, and immunofluorescence

   PMID:23562722

   Open questions at the time

   • In vitro rescue may not reflect in vivo stoichiometry
   • Single lab
   • How the eIF4E–DOZI equilibrium is regulated in gametocytes not established
6. 2021 Medium

   Whether eIF4E is the principal cap-binding protein in intact parasites, versus one of several, was confirmed by native cap-affinity proteomics; eIF4E was the most reproducibly enriched cap-binder, while eIF4A/eIF4G enriched only weakly.

   Evidence 5' cap affinity enrichment of native proteins from asexual-stage lysates with mass spectrometry

   PMID:34890716

   Open questions at the time

   • Loose/transient eIF4F assembly inferred, not directly demonstrated
   • Stage-specific composition of cap-binding complexes not resolved
   • No quantitative comparison across developmental stages
7. 2021 Low

   eIF4E's cap-binding activity was exploited as a reagent to map 5'-capped transcript ends across asexual stages, reinforcing that its cap recognition operates throughout intraerythrocytic development.

   Evidence Cap-affinity enrichment of full-length cDNA coupled with next-generation sequencing

   PMID:34527439

   Open questions at the time

   • Cap-binding inferred from enrichment rather than directly assayed
   • Used instrumentally, not to test eIF4E biology per se
   • No functional readout for eIF4E itself

• How eIF4E is partitioned between the active eIF4F complex and the repressive DOZI/CITH mRNP, and what regulates this switch during the transition to gametocyte stages, remains unresolved.
• No structural model of eIF4E or its complexes
• No eIF4E-specific conditional loss-of-function phenotype
• Regulatory modifications controlling eIF4E partitioning unknown